chr8-144099319-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_030974.4(SHARPIN):c.880C>T(p.Pro294Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0421 in 1,614,110 control chromosomes in the GnomAD database, including 1,665 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_030974.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SHARPIN | NM_030974.4 | c.880C>T | p.Pro294Ser | missense_variant | 6/9 | ENST00000398712.7 | NP_112236.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SHARPIN | ENST00000398712.7 | c.880C>T | p.Pro294Ser | missense_variant | 6/9 | 1 | NM_030974.4 | ENSP00000381698 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0311 AC: 4725AN: 152172Hom.: 96 Cov.: 33
GnomAD3 exomes AF: 0.0306 AC: 7621AN: 249246Hom.: 164 AF XY: 0.0306 AC XY: 4138AN XY: 135274
GnomAD4 exome AF: 0.0432 AC: 63214AN: 1461820Hom.: 1569 Cov.: 32 AF XY: 0.0424 AC XY: 30803AN XY: 727216
GnomAD4 genome AF: 0.0310 AC: 4723AN: 152290Hom.: 96 Cov.: 33 AF XY: 0.0300 AC XY: 2236AN XY: 74462
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at